Sentence examples for equivalent progression from inspiring English sources

The end points analyzed in our in vivo studies clearly demonstrated an equivalent progression and outcome of disease in SP-A-/ and wild-type mice.

In early trials in the metastatic setting, capecitabine demonstrated response rate superior to those achieved with the Mayo Clinic regimen of 5-FU/LV (26% vs 17%), with equivalent progression- free survival and overall survival.

In a phase III trial of Abraxane plus carboplatin versus solvent-based paclitaxel [ 11], Abraxane arm shows significantly higher ORR than the solvent-based paclitaxel arm (33% vs 25%, p = 0.005) and equivalent progression free survival (PFS) and OS.

This trial showed equivalent progression free survival (PFS) in both weekly and 2 weekly T (82% in weekly versus 81% in dd PFS), suggesting that weekly paclitaxel could have the same efficacy without the patients having to receive the growth factor support.

Even though all those with HD have the same type of mutation, two individuals with precisely the same HD CAG length are unlikely to present with movement disorder at exactly the same age (for example, Figure 1), display the identical psychiatric, cognitive or peripheral phenotypes, show equivalent progression of phenotypes, or suffer death after an equal disease duration.

Large scale record linkage has now allowed the sorts of comparison that are described here, and those data suggest that the standard for PLAB has in recent years been set too low if equivalent progression by PLAB graduates to UK graduates is expected and required.

However, no patient subgroup could be identified for which carboplatin had achieved an equivalent progression-free survival rate to cisplatin-based treatment.

O'Brien et al. reported that, compared to doxorubicin, PLD provides equivalent progression-free survival (PFS; 7.8 vs. 6.9 months, respectively) and overall survival (OS; 22 and 21 months, respectively) when used as the first-line therapy for MBC [ 6].

At follow-up sampling after 3 4 weeks of therapy, patients with a CTC level ≥ 5 at baseline whose CTCs were reduced to < 5 had equivalent progression-free survival and OS to patients who began treatment with < 5 CTCs.

The addition of cetuximab to first line chemotherapy in a recently presented phase III randomised trial, in 696 patients with advanced disease, showed equivalent progression-free survival (4.2 versus 4.4 months) according to independent radiology review[ 32 ].

In early trials in the metastatic setting, capecitabine has shown superior response rates compared with those achieved with 5-FU (Mayo Clinic regimen) (26% vs 17%), with equivalent progression-free survival and overall survival.